Richard L Mackman Selected Research

Richard L Mackman Research Topics

7	COVID-19 03/2022 - 09/2021
3	Infections 01/2018 - 08/2015
3	Respiratory Syncytial Virus Infections 08/2015 - 08/2014
2	Chronic Hepatitis B 01/2020 - 01/2020
2	Hepatitis C 11/2018 - 01/2017
2	Ebola Hemorrhagic Fever 01/2017 - 01/2017
2	Body Weight (Weight, Body) 08/2015 - 02/2008
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022
1	Coronavirus Infections 01/2022
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2022
1	Coinfection 01/2018
1	Virus Diseases (Viral Diseases) 01/2017

9	Antiviral Agents (Antivirals)IBA 01/2022 - 02/2015
8	remdesivirIBA 03/2022 - 01/2017
5	ProdrugsIBA 03/2022 - 01/2017
3	NucleosidesIBA 03/2022 - 01/2017
2	VaccinesIBA 01/2022 - 01/2017
2	GS-621763IBA 01/2022 - 09/2021
2	GS-441524IBA 01/2022 - 09/2021
2	Toll-Like Receptor 8IBA 01/2020 - 01/2020
2	selgantolimodIBA 01/2020 - 01/2020
2	Cyclophilins (Cyclophilin)IBA 11/2018 - 01/2017
2	presatovirIBA 08/2015 - 08/2014
1	phosphoramidic acidIBA 03/2022
1	NucleotidesIBA 02/2022
1	COVID-19 VaccinesIBA 09/2021
1	IsomerasesIBA 11/2018
1	ExoribonucleasesIBA 01/2018
1	ProTidesIBA 01/2017
1	Pharmaceutical PreparationsIBA 01/2017
1	Adenosine (Adenocard)FDA LinkGeneric 01/2017
1	GS-9148IBA 02/2008
1	GS-9131IBA 02/2008
1	Diphosphates (Pyrophosphates)IBA 02/2008

2	Therapeutics 01/2018 - 01/2017
1	Intravenous Administration 08/2015
1	Oral Administration 02/2008